Loading…
Loading the latest PSX data…
Loading the latest PSX data…
The Searle Company Limited (SEARL) against the KSE-100 index: performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-10
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | SEARLPharmaceuticals |
|---|---|
| danioPSX score | 53 |
| Price and size | |
| Price | Rs 80.40 |
| Today | +1.49% |
| Market cap | Rs 47.3bn |
| Traded per day | Rs 108m |
| Valuation and dividends | |
| P/E | 12.2 |
| Dividend yield | – |
| EPS (last year) | Rs 6.81 |
| Business | |
| EPS growth | +820.3% |
| Sales growth | +27.7% |
| Net margin | 12.7% |
| Returns | |
| 1 month | +3.5% |
| 3 months | −12.2% |
| 1 year | −24.6% |
| vs KSE-100, 1 year | -37.7 pts |
| Trend and risk | |
| 52-week position | 10% |
| RSI 14 | 55 |
| RS rank | 18 |
| Volatility | 40% |
| Beta | 1.27 |
| danioPSX score | |
| Value | 51 |
| Quality | 79 |
| Dividend | 18 |
| Momentum | 19 |
| Safety | 65 |
| Shariah-compliant | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener